Your browser doesn't support javascript.
loading
Author Correction: Pharmacokinetics, mass balance, and metabolism of [14C]vicagrel, a novel irreversible P2Y12 inhibitor in humans.
Zheng, Yuan-Dong; Zhang, Hua; Zhan, Yan; Bian, Yi-Cong; Ma, Sheng; Gan, Hai-Xian; Lai, Xiao-Juan; Liu, Yong-Qiang; Gong, Yan-Chun; Liu, Xue-Fang; Sun, Hong-Bin; Li, Yong-Guo; Zhong, Da-Fang; Miao, Li-Yan; Diao, Xing-Xing.
  • Zheng YD; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Zhang H; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Zhan Y; Department of Clinical Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou, 215123, China.
  • Bian YC; Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, 215006, China.
  • Ma S; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Gan HX; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Lai XJ; Department of Clinical Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou, 215123, China.
  • Liu YQ; Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, 215006, China.
  • Gong YC; Department of Clinical Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou, 215123, China.
  • Liu XF; Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, 215006, China.
  • Sun HB; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
  • Li YG; Jiangsu Vcare PharmaTech Co. Ltd., Nanjing, 211800, China.
  • Zhong DF; Jiangsu Vcare PharmaTech Co. Ltd., Nanjing, 211800, China.
  • Miao LY; Jiangsu Vcare PharmaTech Co. Ltd., Nanjing, 211800, China.
  • Diao XX; Jiangsu Vcare PharmaTech Co. Ltd., Nanjing, 211800, China.
Acta Pharmacol Sin ; 44(12): 2549, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37532785